Finance

Lists
ANIK:NASDAQ
Anika Therapeutics Inc
20,40 $
-1,40%
(-0,29) 1D
16 қаз., 11:27:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANIK...
Open
20,73 $
High
20,75 $
Low
20,24 $
Mkt. cap
273,01 млн
Avg. vol.
89,59 мың
Volume
11,16 мың
52-wk high
22,88 $
52-wk low
8,67 $
EPS
-0,27 $
Beta
0,21
Shares outstanding
13,38 млн
No. of employees
235
Open
20,73 $
High
20,75 $
Low
20,24 $
Mkt. cap
273,01 млн
Avg. vol.
89,59 мың
Volume
11,16 мың
52-wk high
22,88 $
52-wk low
8,67 $
EPS
-0,27 $
Beta
0,21
Shares outstanding
13,38 млн
No. of employees
235
News stories
From web sources and news partners
Investing News Network
Investing News Network
·
21 минут бұрын
BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content Update
Investopedia
Investopedia
·
11 минут бұрын
Nasdaq Poised to End Run of Weekly Gains
MarketBeat
MarketBeat
·
20 минут бұрын
Slide Insurance (NASDAQ:SLDE) Reaches New 1-Year High - Still a Buy?
Reuters
Reuters
·
1 сағат бұрын
Wall St opens muted as tech jitters linger; Tesla gains
About Anika Therapeutics Inc
CEO-
Employees235
Founded1983
HeadquartersБэдфорд, Массачусетс, Америка Құрама Штаттары
Sector-
Websiteanika.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANIK in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANIK in the last 3 months.
Highest
Current 20,40 $
23,00 $ (+12,75%)
Average
23,00 $ (+12,75%)
Lowest
23,00 $ (+12,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
23,00 $
+12,7%
10/01/2026
Madison Elsaadi
B. Riley Securities
Buy
Initiated
23,00 $
+12,7%
09/18/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
21,00 $
+2,9%
07/30/2026
Last report
2026 ж. 29 шіл.
Fiscal period
Q2 2026
0,42 $ / 0,03 $
+1 300,00%beat
Revenue / Est. (USD)
32,61 млн / 29,21 млн
+11,62%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
27,82 млн
30,62 млн
29,61 млн
32,61 млн
Cost of goods sold
12,23 млн
11,44 млн
10,62 млн
11,37 млн
Cost of revenue
12,23 млн
11,44 млн
10,62 млн
11,37 млн
Research and development expenses
6,95 млн
6,45 млн
6,71 млн
7,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,87 млн
12,08 млн
16,18 млн
10,18 млн
Operating expense
18,82 млн
18,53 млн
22,90 млн
17,52 млн
Total operating expenses
31,05 млн
29,97 млн
33,51 млн
28,88 млн
Operating income
-3,23 млн
646,00 м.
-3,90 млн
3,73 млн
Other non operating income
-
-
-
-
EBT including unusual items
-2,24 млн
764,00 м.
-4,82 млн
3,38 млн
EBT excluding unusual items
-2,24 млн
764,00 м.
-3,23 млн
4,15 млн
Income tax expense
939,00 м.
-1,04 млн
235,00 м.
71,00 мың
Effective tax rate
-41,99%
-135,73%
-4,87%
2,10%
Other operating expenses
-
-
-
-
Net income
-2,33 млн
292,00 м.
-5,06 млн
3,31 млн
Net profit margin
-8,37%
0,95%
-17,07%
10,15%
Earnings per share
0,04
0,31
0,27
0,42
Interest and investment income
997,00 м.
118,00 м.
667,00 м.
426,00 м.
Interest expense
-
-
-
-
Net interest expenses
997,00 м.
118,00 м.
667,00 м.
426,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,83 млн
1,96 млн
-2,49 млн
5,23 млн
Gain or loss from assets sale
-451,00 м.
790,00 м.
-52,00 мың
-32,00 мың
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары